Anticoagulation in Remote HIT When VTE Treatment or Prophylaxis Is Required

This protocol addresses patients with a prior history of heparin-induced thrombocytopenia (remote HIT) who subsequently require anticoagulation for venous thromboembolism (VTE) treatment or prophylaxis.

A past episode of HIT changes how anticoagulation must be approached when VTE management is later needed. Using heparin-based agents in this context carries specific risks that guide agent selection.

Evidence-based guidance strongly recommends using a non-heparin anticoagulant in this setting rather than standard heparin-based options.

The full structured regimen — including which agents qualify, how to select among them, and the supporting evidence grading — is available via the protocol link below.